Hillman Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-22,062
Closed -$5.23M 53
2021
Q2
$5.23M Sell
22,062
-52
-0.2% -$11.8K 1.99% 32
2021
Q1
$4.84M Sell
22,114
-49
-0.2% -$9.83K 2.13% 31
2020
Q4
$3.88M Buy
22,163
+103
+0.5% +$17.8K 2.09% 30
2020
Q3
$3.57M Sell
22,060
-25
-0.1% -$3.96K 2.51% 23
2020
Q2
$3.15M Sell
22,085
-30
-0.1% -$4.15K 2.3% 23
2020
Q1
$2.4M Buy
22,115
+3,315
+18% +$478K 2.3% 27
2019
Q4
$2.73M Buy
+18,800
New +$2.71M 1.94% 29
2013
Q4
$671K Buy
8,543
+132
+2% +$11.3K 1% 36
2013
Q3
$734K Sell
8,411
-4,656
-36% -$392K 1.12% 35
2013
Q2
$1.1M Buy
+13,067
New +$1.08M 1.53% 23

Other funds holding LH

Hillman Capital Management's LH Position: Q3 2021 in Review

Hillman Capital Management sold out of Labcorp (LH) in Q3 2021, closing a stake of 22,062 shares — an estimated $5.23M sold.

Hillman Capital Management first reported a position in LH in Q2 2013 and held it in 10 quarters. The position peaked at $5.23M in Q2 2021. 993 funds tracked by Wall St. Rank hold LH as of Q3 2021.

  • Hillman Capital Management reported no remaining Labcorp position as of Q3 2021 after selling out during the quarter.
  • Hillman Capital Management sold 22,062 Labcorp shares in Q3 2021, an estimated $5.23M.
  • Hillman Capital Management first reported a position in Labcorp in Q2 2013 and held it in 10 quarters.
  • Hillman Capital Management's Labcorp position peaked at $5.23M in Q2 2021.
  • 993 funds tracked by Wall St. Rank held Labcorp as of Q3 2021.

Based on Hillman Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.